De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation.

被引：0
|
作者：
Petrossian, G. [1 ]
Ortiz, J. [2 ]
Addonizio, K. [1 ]
Hsiao, A. [1 ]
Teixeira, L. [1 ]
Koizumi, N. [3 ]
James, R. [3 ]
Patel, S. [4 ]
Conti, D. [2 ]
Plews, R. [2 ]
机构：
[1] Albany Med Ctr, Albany, NY USA
[2] Albany Med Ctr, Div Renal & Pancreat Transplant Serv, Albany, NY USA
[3] George Mason Univ, Fairfax, VA 22030 USA
[4] UMC Las Vegas, Las Vegas, NV USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
413
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [21] Shockwave Lithotripsy for De-Novo Urolithiasis after Kidney Transplantation: A Systematic Review of the Literature
    Cerrato, Clara
    Jahrreiss, Victoria
    Nedbal, Carlotta
    Ripa, Francesco
    De Marco, Vincenzo
    Monga, Manoj
    Pietropaolo, Amelia
    Somani, Bhaskar
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [22] IMPACT OF DE-NOVO MEMBRANOUS GLOMERULONEPHRITIS ON THE CLINICAL COURSE AFTER KIDNEY-TRANSPLANTATION
    SCHWARZ, A
    KRAUSE, PH
    OFFERMANN, G
    KELLER, F
    TRANSPLANTATION, 1994, 58 (06) : 650 - 654
  • [23] The Successful Use of De Novo Belatacept with Reduced Dose Tacrolimus to Mitigate the Risks of Delayed Graft Function in Kidney Transplantation.
    Siskind, E.
    Splinter, J.
    Taing, C.
    Adekile, A.
    Njim, S.
    Shah, S.
    Plews, R.
    Conti, D.
    Patel, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1091 - 1091
  • [24] De novo minimal change disease after kidney transplantation
    Alirezaei, Amirhesam
    Zare, Elham
    Parvin, Mahmoud
    Nili, Fatemeh
    Bakhtiyari, Mahmood
    JOURNAL OF RENAL INJURY PREVENTION, 2018, 7 (02): : 103 - 106
  • [25] Everolimus Is Associated With a Reduced Incidence of Herpes Zoster Following De Novo Kidney Transplantation.
    Goto, N.
    Nishihira, M.
    Hidaka, Y.
    Yamamoto, T.
    Tsujita, M.
    Hiramitsu, T.
    Narumi, S.
    Kabayashi, T.
    Watarai, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 623 - 624
  • [26] Increased Risk of Cardiovascular Disease in Patients After Hand Transplantation.
    Magott-Procelewska, M.
    Boratynska, M.
    Banasik, M.
    Chelmonski, A.
    Jablecki, J.
    Klinger, M.
    TRANSPLANTATION, 2014, 98 : 412 - 412
  • [27] Increased Risk of Cardiovascular Disease in Patients After Hand Transplantation.
    Magott-Procelewska, M.
    Boratynska, M.
    Banasik, M.
    Chelmonski, A.
    Jableeki, J.
    Klinger, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 412 - 412
  • [28] INTERACTION BETWEEN CMV/EBV VIRUSES AND DE NOVO COLONIC TUMOUR AFTER KIDNEY TRANSPLANTATION
    Adani, Gian Luigi
    Baccarani, Umberto
    Lorenzin, Dario
    Tulissi, Patrizia
    Montanaro, Domenico
    Bresadola, Vittorio
    TRANSPLANT INTERNATIONAL, 2009, 22 : 22 - 22
  • [29] Contrary to Persisting De-Novo DSA, Transient De-Novo DSAs After Lung Transplantation Do Not Constitute a Risk Factor for Patient and Graft Survival
    Benazzo, A.
    Nechay, A.
    Auner, S.
    Boehm, P. M.
    Schwarz, S.
    Schweiger, T.
    Ozy, G. Murak
    Taghavi, S.
    Klepetko, W.
    Hoetzenecker, K.
    Jaksch, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S157 - S157
  • [30] Efficacy of Preemptive Therapy with CMV Antigenemia Titer ≥50/4x105 Leukocytes for Prevention of CMV Disease after Kidney Transplantation.
    Jung, Gum O.
    Moon, Joo Ik
    Kim, Jong Man
    Choi, Gyu-Seong
    Park, Jae Berm
    Kwon, Choon Hyuck David
    Lee, Suk-Koo
    Joh, Jae-Won
    Kim, Sung-Joo
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 679 - 680
12345